Literature DB >> 16929323

Hepatocellular carcinoma pathogenesis: from genes to environment.

Paraskevi A Farazi1, Ronald A DePinho.   

Abstract

Hepatocellular carcinoma is among the most lethal and prevalent cancers in the human population. Despite its significance, there is only an elemental understanding of the molecular, cellular and environmental mechanisms that drive disease pathogenesis, and there are only limited therapeutic options, many with negligible clinical benefit. This Review summarizes the current state of knowledge of this, the most common and dreaded liver neoplasm, and highlights the principal challenges and scientific opportunities that are relevant to controlling this accelerating global health crisis.

Entities:  

Mesh:

Year:  2006        PMID: 16929323     DOI: 10.1038/nrc1934

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  802 in total

1.  Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.

Authors:  Naushad Ali; Heba Allam; Randal May; Sripathi M Sureban; Michael S Bronze; Ted Bader; Shahid Umar; Srikant Anant; Courtney W Houchen
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.

Authors:  Xue-Xi Yang; Jing-Zhe Sun; Fen-Xia Li; Ying-Song Wu; Hong-Yan Du; Wei Zhu; Xiang-Hong Li; Ming Li
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 3.  Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science.

Authors:  Shinji Tanaka; Shigeki Arii
Journal:  Int J Clin Oncol       Date:  2010-05-27       Impact factor: 3.402

4.  Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling.

Authors:  Xu-Feng Zhang; Xinping Tan; Gang Zeng; Amalea Misse; Sucha Singh; Youngsoo Kim; James E Klaunig; Satdarshan P S Monga
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

5.  Accelerated carcinogenesis following liver resection in chronically inflamed livers: A window of opportunity for treatment.

Authors:  Amir Sonnenblick; Tamar Zahavi
Journal:  Biomed Rep       Date:  2017-03-30

Review 6.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

7.  Liver cancer: time to evolve trial design after everolimus failure.

Authors:  Josep M Llovet
Journal:  Nat Rev Clin Oncol       Date:  2014-08-05       Impact factor: 66.675

8.  Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma.

Authors:  Fu-Yao Liu; Yue-Ling Deng; Yuan Li; Dan Zeng; Zhen-Zhen Zhou; De-An Tian; Mei Liu
Journal:  Med Oncol       Date:  2013-01-17       Impact factor: 3.064

9.  Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway.

Authors:  Charlotte E Edling; Federico Selvaggi; Ragheda Ghonaim; Tania Maffucci; Marco Falasca
Journal:  Cancer Biol Ther       Date:  2014-02-12       Impact factor: 4.742

Review 10.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.